Skip to main content

Table 4 Results of multivariate analysis of prognostic factors for NPC patients

From: Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma

Factor (s) B SE Wald df P Exp (B) 95.0% CI for Exp (B)
Lower Upper
Gender 0.102 0.354 0.083 1 0.774 1.107 0.553 2.218
Age − 0.142 0.331 0.184 1 0.668 0.868 0.453 1.661
T stage − 0.130 0.413 0.100 1 0.042 1.078 0.391 1.972
LNM 1.591 0.415 14.730 1 0.000 4.910 2.179 11.067
N stage 2.328 0.774 9.034 1 0.003 10.253 2.247 46.780
Differentiation type 0.006 0.371 0.000 1 0.988 1.0006 0.486 2.079
Clinical stage 3.247 0.608 28.516 1 0.000 25.701 7.807 84.615
Smoking 0.749 0.361 4.299 1 0.380 0.116 0.102 1.296
Family history − 1.038 0.538 3.727 1 0.054 0.354 0.123 1.016
JAK2 1.583 0.461 11.812 1 0.001 4.868 1.974 12.006
STAT3 − 0.041 0.397 0.010 1 0.018 1.960 0.441 2.092
VEGF − 0.820 0.609 1.815 1 0.017 1.440 0.133 1.453
  1. NPC nasopharyngeal carcinoma, LNM lymph-node metastasis, JAK2 Janus kinase 2, STAT3 Signal transducer and activator of transcription-3, VEGF Vascular endothelial growth factor